instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: The National Park Service and the U.S. Public Health Service told the San Francisco Chronicle they launched an investigation after employees and visitors reported the problems this month. Federal officials said they haven’t identified the illness or the origin of the outbreak. Park officials said those who had gotten sick are getting better or already recovered. Federal officials were working with Aramark, the concessionaire that operates Yosemite’s restaurants, snack shops and hotels, to clean up and disinfect food service facilities in the park, including the famous Ahwahnee Hotel, Yosemite spokesman Scott Gediman said. “The park is reminding all employees and visitors to wash their hands frequently and stay home if they experience any symptoms of a gastrointestinal illness,” Gediman said in a statement. A message seeking comment from a spokesman for Aramark has not been returned. Aramark received numerous complaints from visitors about poor food quality, shuttle service and other services since it began managing Yosemite’s concessions four years ago. The Ahwahnee Hotel lost its prestigious four-diamond rating by AAA, a distinction the luxury hotel held since 1991, and is now listed as a three-diamond hotel. Visitors to the hotel at the foot of the iconic Half Dome have included Queen Elizabeth II and U.S. presidents. Claim: Stomach illness outbreak at Yosemite prompts major clean-up.
answer:
Federal health officials are inspecting Yosemite National Park’s food service areas after at least a dozen people have fallen ill with stomach issues.


question:
Paragraph: Shares of the company traded marginally down at $132.47, after having closed up 1.7% on Monday. (bit.ly/2ZkZGze)    J&J said that the FTC had issued a “civil investigative demand,” or CID, the equivalent of a subpoena to determine if the contracting practices were legal. Pfizer Inc filed a lawsuit against J&J in 2017, saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and aimed at blocking sales of Pfizer’s biosimilar called Inflectra. Pfizer said in the lawsuit that J&J had contracted with many insurers to give discounts in exchange for giving preference to Remicade, and to only pay for Inflectra in cases where Remicade proved to be ineffective. Inflectra was approved in 2016 while Remicade went on the market in 1998. Remicade is an infused treatment for chronic autoimmune disorders and costs about $4,000 per dose, or $26,000 a year, Pfizer said in the lawsuit. J&J has denied any wrongdoing and is fighting the Pfizer lawsuit. Pfizer said in a statement that it had received a CID in June. “As Pfizer’s complaint alleges, J&J’s unlawful conduct is designed to prevent Inflectra from being able to compete on its primary point of differentiation – price. Today, Inflectra has an average selling price (ASP) that is more than 22% lower than Remicade,” the company said in a statement. “Despite these facts, J&J has not lost substantial volume or share of sales – counter to what should occur in a competitive market.”  Biosimilars are intended to be lower-cost alternatives to expensive biotech medicines. But since they are made from living cells and it is not possible to make an exact copy of the branded medicine, they are not automatically substituted for the existing branded drug the way a generic drug would be. The drugs treat ailments like rheumatoid arthritis, Crohn’s disease and ulcerative colitis. Claim: J&J says FTC probing efforts to protect arthritis drug Remicade.
answer:
The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.


question:
Paragraph: A person carrying the novel coronavirus in Norway contaminates now on average 0.7 other individuals, Bent Hoeie told a news conference. The government’s goal had been to limit the spread to maximum one other person. “Before we implemented tough restrictions, every contaminated person in Norway infected 2.5 other individuals on average,” Hoeie said. “If this development had been allowed to continue, we would probably have been in the same situation that we have seen in some countries in Europe.”  The Norwegian government announced three weeks ago  emergency shutdowns of many public and private institutions, including schools and kindergartens, sending the economy into a tailspin and triggering hundreds of thousands of layoffs. The government will decide on Wednesday whether to extend the restrictions beyond mid-April. It was not immediately clear which measures could be lifted, nor when they would be. Local authorities in the capital Oslo and Trondheim, Norway’s third-largest city, have already said they will not reopen schools and nurseries by mid-April because they needed more time to prepare. The Norwegian Institute of Public Health (FHI) said on Monday the number of coronavirus cases in the country stood at 5,755 people, with 59 deaths. The FHI also estimated for the first time on Monday that around 14,000 people in total may be carrying the virus in Norway, or 0.26% of the population. “It is good news. It shows the restrictions have worked,” Camilla Stoltenberg, the head of the institute, told public broadcaster NRK. “(But) we don’t know which specific measures worked.” Claim: Coronavirus epidemic 'under control' in Norway: health minister.
answer:

The coronavirus epidemic is “under control” in Norway, the health minister said on Monday, pointing to the low rate of transmission of the disease.